Lung Function in Patients With Early Type 2 Diabetes Mellitus

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT03167918

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Liaoning University of Traditional Chinese Medicine (from the registry)
Registry
  • NCT NCT03167918
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03167918. Randomized; double masking; primary purpose treatment. Start 2014-07-21 (actual); primary completion 2017-04-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Lung Function in Patients With Early Type 2 Diabetes Mellitus
Condition
Type 2 Diabetes Mellitus
Condition
Pulmonary Function
Intervention (Drug)
Calcium Dobesilate
Intervention (Drug)
Xuefuzhuyu Decoction
Intervention (Drug)
Xuefuzhuyu Decoction & Calcium dobesilate
Intervention (Drug)
metformin
Intervention (Drug)
Mecobalamin Tablets
Lead sponsor
Liaoning University of Traditional Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct03167918
Content hash
e02e07204f99d7fbabbaf582d1bc30eb2721100f39ba8ccc92553281b46a07d2